PubRank

Peter Henklein

Author PubWeight™ 68.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc Natl Acad Sci U S A 2007 2.97
2 An essential role for tripeptidyl peptidase in the generation of an MHC class I epitope. Nat Immunol 2003 2.38
3 SIRT1 regulates HIV transcription via Tat deacetylation. PLoS Biol 2005 2.24
4 Sequence requirements and an optimization strategy for short antimicrobial peptides. Chem Biol 2006 1.84
5 Hepatitis C virus mutation affects proteasomal epitope processing. J Clin Invest 2004 1.58
6 Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J 2003 1.53
7 Transcriptional synergy between Tat and PCAF is dependent on the binding of acetylated Tat to the PCAF bromodomain. EMBO J 2002 1.49
8 An unlocking/relocking barrier in conformational fluctuations of villin headpiece subdomain. Proc Natl Acad Sci U S A 2010 1.47
9 Acetylation of Tat defines a cyclinT1-independent step in HIV transactivation. Mol Cell 2003 1.42
10 Human immunodeficiency virus type 1-induced macrophage gene expression includes the p21 gene, a target for viral regulation. J Virol 2005 1.37
11 Antibody to AP1B adaptor blocks biosynthetic and recycling routes of basolateral proteins at recycling endosomes. Mol Biol Cell 2007 1.35
12 Sequence of interactions in receptor-G protein coupling. J Biol Chem 2004 1.15
13 Signal transfer from GPCRs to G proteins: role of the G alpha N-terminal region in rhodopsin-transducin coupling. J Biol Chem 2006 1.14
14 HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis. Virology 2002 1.14
15 Structural characterization and oligomerization of PB1-F2, a proapoptotic influenza A virus protein. J Biol Chem 2006 1.12
16 Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 2009 1.08
17 Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J Biol Chem 2003 1.05
18 Solution structure of the human immunodeficiency virus type 1 p6 protein. J Biol Chem 2005 1.04
19 Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 2003 1.02
20 Using intrinsic X-ray absorption spectral differences to identify and map peptides and proteins. J Phys Chem B 2007 1.02
21 Tat acetylation: a regulatory switch between early and late phases in HIV transcription elongation. Novartis Found Symp 2004 1.01
22 The uronium/guanidinium Peptide coupling reagents: finally the true uronium salts. Angew Chem Int Ed Engl 2002 1.00
23 Screening and characterization of surface-tethered cationic peptides for antimicrobial activity. Chem Biol 2009 0.98
24 Helix formation in arrestin accompanies recognition of photoactivated rhodopsin. Biochemistry 2009 0.96
25 The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing. J Mol Biol 2002 0.96
26 The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One 2010 0.96
27 Structural characterization of the HIV-1 Vpr N terminus: evidence of cis/trans-proline isomerism. J Biol Chem 2003 0.94
28 Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion. Carcinogenesis 2009 0.92
29 PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism. Oncol Res 2004 0.92
30 Antitopes define preferential proteasomal cleavage site usage. J Biol Chem 2008 0.92
31 Highly conserved serine residue 40 in HIV-1 p6 regulates capsid processing and virus core assembly. Retrovirology 2011 0.90
32 Rhodopsin-transducin coupling: role of the Galpha C-terminus in nucleotide exchange catalysis. Vision Res 2006 0.89
33 The N-terminal flanking region of the TRP2360-368 melanoma antigen determines proteasome activator PA28 requirement for epitope liberation. J Biol Chem 2007 0.89
34 PAR-type thrombin receptors in renal carcinoma cells: PAR1-mediated EGFR activation promotes cell migration. Oncol Rep 2006 0.89
35 Thrombin-mediated hepatocellular carcinoma cell migration: cooperative action via proteinase-activated receptors 1 and 4. J Cell Physiol 2007 0.88
36 Generation of in silico predicted coxsackievirus B3-derived MHC class I epitopes by proteasomes. Amino Acids 2009 0.87
37 HIV-1 p6 - a structured to flexible multifunctional membrane-interacting protein. Biochim Biophys Acta 2012 0.85
38 Proteinase-activated receptors (PARs)--the PAR3 Neo-N-terminal peptide TFRGAP interacts with PAR1. Regul Pept 2005 0.85
39 Exogenous HIV-1 Vpr disrupts IFN-alpha response by plasmacytoid dendritic cells (pDCs) and subsequent pDC/NK interplay. Immunol Lett 2009 0.85
40 Influenza A virus protein PB1-F2 from different strains shows distinct structural signatures. Biochim Biophys Acta 2012 0.84
41 Hepatitis B virus HBx peptide 116-138 and proteasome activator PA28 compete for binding to the proteasome alpha4/MC6 subunit. Biol Chem 2003 0.84
42 The COP9 signalosome-mediated deneddylation is stimulated by caspases during apoptosis. Apoptosis 2008 0.84
43 Proline 35 of human immunodeficiency virus type 1 (HIV-1) Vpr regulates the integrity of the N-terminal helix and the incorporation of Vpr into virus particles and supports the replication of R5-tropic HIV-1 in human lymphoid tissue ex vivo. J Virol 2007 0.83
44 Synthesis of full length PB1-F2 influenza A virus proteins from 'Spanish flu' and 'bird flu'. J Pept Sci 2008 0.83
45 Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab 2006 0.83
46 Thymulin gene therapy prevents the reduction in circulating gonadotropins induced by thymulin deficiency in mice. Am J Physiol Endocrinol Metab 2007 0.83
47 Identification and characterization of SmD183-119-reactive T cells that provide T cell help for pathogenic anti-double-stranded DNA antibodies. Arthritis Rheum 2003 0.82
48 Sorting competition with membrane-permeable peptides in intact epithelial cells revealed discrimination of transmembrane proteins not only at the trans-Golgi network but also at pre-Golgi stages. J Biol Chem 2004 0.82
49 Structure, dynamics and topology of membrane polypeptides by oriented 2H solid-state NMR spectroscopy. Eur Biophys J 2006 0.82
50 X-ray spectromicroscopy study of competitive adsorption of protein and peptide onto polystyrene-poly(methyl methacrylate). Biointerphases 2008 0.81
51 Specificity of Chicken (IgY) versus Rabbit (IgG) Antibodies Raised against Cholecystokinin Octapeptide (CCK-8). ALTEX 1996 0.81
52 The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding. BMC Struct Biol 2010 0.81
53 The host-pathogen interaction of human cyclophilin A and HIV-1 Vpr requires specific N-terminal and novel C-terminal domains. BMC Struct Biol 2011 0.81
54 The cell-penetrating peptide octa-arginine is a potent inhibitor of proteasome activities. Eur J Pharm Biopharm 2008 0.81
55 Green tea polyphenol epigallocatechin-3-gallate inhibits thrombin-induced hepatocellular carcinoma cell invasion and p42/p44-MAPKinase activation. Oncol Rep 2009 0.80
56 HIV-1 p6-Another viral interaction partner to the host cellular protein cyclophilin A. Biochim Biophys Acta 2012 0.80
57 Dicyclopropylmethyl peptide backbone protectant. Org Lett 2009 0.78
58 ORF8a of SARS-CoV forms an ion channel: experiments and molecular dynamics simulations. Biochim Biophys Acta 2010 0.78
59 Complex polyfluoride additives in Fmoc-amino acid fluoride coupling processes. Enhanced reactivity and avoidance of stereomutation. Org Lett 2003 0.78
60 Solution structure of the equine infectious anemia virus p9 protein: a rationalization of its different ALIX binding requirements compared to the analogous HIV-p6 protein. BMC Struct Biol 2009 0.77
61 Phage display screening for peptidic chitinase inhibitors. J Mol Recognit 2008 0.77
62 Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications. Chem Commun (Camb) 2005 0.77
63 Modulating the activity of the channel-forming segment of Vpr protein from HIV-1. Eur Biophys J 2009 0.77
64 Design and biological evaluation of photo-switchable inhibitors. Genome Inform 2006 0.76
65 Synthesis and spectroscopic characterization of photo-affinity peptide ligands to study rhodopsin-G protein interaction. Photochem Photobiol 2008 0.76
66 Identification of HIV-1 Tat peptides for future therapeutic angiogenesis. Eur J Haematol 2006 0.76
67 On the use of N-dicyclopropylmethyl aspartyl-glycine synthone for backbone amide protection. J Pept Sci 2010 0.75
68 Inhibition of Helicobacter pylori urease activity in vivo by the synthetic nickel binding protein Hpn. Eur J Microbiol Immunol (Bp) 2013 0.75
69 A photo-cross-linking strategy to map sites of protein-protein interactions. Chemistry 2010 0.75
70 Inhibiting the inhibitors: retro-inverso Smac peptides. Peptides 2009 0.75
71 The Dcpm protecting group is a useful alternative to the Hmb residue. Adv Exp Med Biol 2009 0.75
72 Production, purification, and characterization of rat pro-CCK from serum-free adapted Drosophila cells. Protein Expr Purif 2003 0.75